What Pharmacists Should Know About Long COVID and Brain Health
Summary of the Provided Text: Long COVID & Brain Changes
This article discusses recent research highlighting the lasting neurological effects of COVID-19, even in individuals who believe they have fully recovered. Here’s a breakdown of the key points:
* Study Details: A study using MRI scans on 47 participants (19 with long COVID,12 recovered & healthy,16 healthy controls) revealed altered brain signal intensity and tissue microstructure in all groups compared to healthy controls. Meaningful changes were found between long COVID patients and those who had recovered.
* Key Findings:
* Brain Changes Persist: MRI scans showed alterations in brain neurochemicals, signal intensity, and tissue structure not just in long COVID patients, but also in those who thought they had recovered.
* Correlation with Symptoms: Altered brain tissue in long COVID patients was linked to the severity of their symptoms.
* Cognitive Impact: These brain changes are believed to contribute to cognitive issues like memory problems and difficulty concentrating.
* Long COVID Defined: The CDC defines long COVID as a serious illness with chronic symptoms lasting weeks, months, or years after initial infection.
* Risk Factors for Long COVID: Women, Hispanic/Latino individuals, those with severe initial illness, underlying health conditions, and unvaccinated individuals are at higher risk.
* Pharmacist Role: Pharmacists should be aware of these potential long-term neurological effects and recognize symptoms like brain fog, memory issues, slowed thinking, and fatigue as potential signs of long COVID.
In essence, the research underscores that COVID-19 can have a “silent, lasting effect” on brain health, even in seemingly recovered individuals, and highlights the importance of awareness among healthcare professionals like pharmacists.